Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Rezolute, Inc. Director's Dealing 2014

May 2, 2014

32362_dirs_2014-05-02_1a4112d0-aa7b-4386-ab63-d2568df70876.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: AntriaBio, Inc. (ANTB)
CIK: 0001509261
Period of Report: 2014-04-30

Reporting Person: Huh Hoyoung (Director, 10% Owner)

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2012-04-30 Stock Option (right to buy) $3.12 A 350000 Acquired 2019-04-30 Common Stock (350000) Direct

Footnotes

F1: The option vests in forty-eight equal installments beginning on the date so indicated and every month thereafter, such grant vested in full at 4 years.